Key Highlights
- USA Rare Earth finalized its acquisition of Texas Mineral Resources on Thursday, closing a transaction initially announced on March 4, 2026
- Shares of USAR surged 7.5% to reach $20.00, extending the year-to-date gain to 56% with a market capitalization of $4.55 billion
- Former Texas Mineral Resources investors obtained 0.043279843 USAR shares per share owned
- Wall Street consensus shows nine analysts with Buy ratings and an average price target of $35.83; Northland Securities maintains a $45 objective
- Second quarter 2026 revenue totaled $5.82 million, falling short of the $8 million analyst projection; adjusted EPS loss of $0.15 exceeded the anticipated $0.07 deficit
Shares of USA Rare Earth (USAR) advanced 7.5% to close at $20.00 on Friday, reaching an intraday peak of $20.50. The rally occurred as the company announced the successful conclusion of its acquisition of Texas Mineral Resources Corp.
The transaction, initially announced on March 4, 2026, utilized a dual-step merger framework. Initially, a fully owned USA Rare Earth subsidiary combined with Texas Mineral Resources. Subsequently, an additional subsidiary merged with the resulting combined company.
Former Texas Mineral Resources investors obtained 0.043279843 shares of USAR stock for every share in their possession. The conversion ratio reflected 88,339,693 Texas Mineral Resources shares outstanding on a fully diluted basis at completion. Any fractional share amounts were settled in cash payments.
The distribution of USAR equity to previous Texas Mineral Resources stakeholders received registration approval under the Securities Act of 1933. The corresponding Form S-4 registration documentation gained effectiveness on June 29, 2026.
Friday’s price increase extended beyond the merger announcement. The rare earth sector experienced widespread gains, with MP Materials climbing 8% and NioCorp advancing approximately 3%. Growing interest in domestic critical mineral infrastructure fueled the industry-wide momentum.
Wall Street Coverage
Professional analysts covering USAR maintain predominantly optimistic outlooks. Ten analysts track the equity, with nine issuing Buy recommendations. The mean price objective stands at $35.83, compared to the current trading level of $20.00.
Northland Securities maintained its Outperform designation with a $45 price objective. The firm projects USAR approaching breakeven profitability around fiscal 2028. Benchmark Co. sustained its Buy recommendation. Cantor Fitzgerald confirmed an Overweight stance with a $40 target price.
Some dissenting voices exist. Roth Capital reduced its price objective from $40 to $30, while maintaining a Buy designation. Weiss Ratings lowered the stock to a “sell (d-)” rating. Canaccord Genuity increased its target from $29 to $32.
Second Quarter Results Disappoint
USAR disclosed its Q2 2026 financial performance on August 10. Revenue reached $5.82 million, significantly trailing the $8 million Wall Street projection.
The adjusted earnings per share deficit registered at $0.15, exceeding the $0.07 consensus loss estimate. Wall Street projects a full fiscal year EPS loss of $0.47. The company continues operating at a loss.
Regarding insider transactions, Director Carolyn Trabuco divested 13,000 shares on June 8 at $22.77 per share, decreasing her holdings by 40.9%.
Multiple institutional investors have expanded their positions. Weiss Asset Management established a fresh position valued at approximately $17.1 million during Q1. Encompass Capital Advisors initiated a stake worth roughly $7 million. Swiss National Bank increased its holdings by 67.6% in the identical quarter.
USAR has appreciated 56% since the beginning of the year. The 50-day moving average sits at $18.91 while the 200-day moving average registers at $20.45. The equity maintains a beta coefficient of 2.55.


